Cited by 151Cannabis and Cannabinoid ResearchMitochondrial Function and PathologyAdipose Tissue and Metabolism

Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor

Open access
Hebert-Chatelain, Etienne, Reguero, Leire, Puente, Nagore, Lutz, Beat, Chaouloff, Francis, Rossignol, Rodrigue, Piazza, Pier-Vincenzo, Benard, Giovanni +2 more·2014·Molecular Metabolism

Abstract

Brain mitochondrial activity is centrally involved in the central control of energy balance. When studying mitochondrial functions in the brain, however, discrepant results might be obtained, depending on the experimental approaches. For instance, immunostaining experiments and biochemical isolation of organelles expose investigators to risks of false positive and/or false negative results. As an example, the functional presence of cannabinoid type 1 (CB1) receptors on brain mitochondrial membranes (mtCB1) was recently reported and rapidly challenged, claiming that the original observation was likely due to artifact results. Here, we addressed this issue by directly comparing the procedures used in the two studies. Our results show that the use of appropriate controls and quantifications allows detecting mtCB1 receptor with CB1 receptor antibodies, and that, if mitochondrial fractions are enriched and purified, CB1 receptor agonists reliably decrease respiration in brain mitochondria. These data further underline the importance of adapted experimental procedures to study brain mitochondrial functions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmet.2014.03.007

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 36 · Cited by 151

Research works printed but not linked: 27

  1. [1]Bournat J.C. Brown C.W. Mitochondrial dysfunction in obesity Current Opinion in Endocrinology Diabetes and Obesity 17 2010 446 452 PMC5001554 20585248
  2. [5]Sivitz W.I. Yorek M.A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities Antioxidants & Redox Signaling 12 2010 537 577 19650713 PMC2824521
  3. [6]Diano S. Horvath T.L. Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism Trends in Molecular Medicine 18 2012 52 58 21917523
  4. [7]Abizaid A. Horvath T.L. Brain circuits regulating energy homeostasis Regulatory Peptides 149 2008 3 10 18514925 PMC2605273
  5. [8]Sims N.R. Anderson M.F. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation Nature Protocols 3 2008 1228 1239 18600228
  6. [9]Benard G. Massa F. Puente N. Lourenco J. Bellocchio L. Soria-Gomez E. Mitochondrial CB(1) receptors regulate neuronal energy metabolism Nature Neuroscience 15 2012 558 564 22388959
  7. [10]Morozov Y.M. Dominguez M.H. Varela L. Shanabrough M. Koch M. Horvath T.L. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria The European Journal of Neuroscience 38 2013 2341 2348 23617247 PMC3902808
  8. [12]Silvestri C. Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders Cell Metabolism 17 2013 475 490 23562074
  9. [13]Nam D.H. Lee M.H. Kim J.E. Song H.K. Kang Y.S. Lee J.E. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice Endocrinology 153 2012 1387 1396 22234468
  10. [14]Vickers S.P. Webster L.J. Wyatt A. Dourish C.T. Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats Psychopharmacology 167 2003 103 111 12632249
  11. [15]Pagotto U. Marsicano G. Cota D. Lutz B. Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocrine Reviews 27 2006 73 100 16306385
  12. [16]Bartova A. Birmingham M.K. Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity The Journal of Biological Chemistry 251 1976 5002 5006 956173
  13. [17]Matsuda L.A. Lolait S.J. Brownstein M.J. Young A.C. Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564 2165569
  14. [18]Munro S. Thomas K.L. Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 7689702
  15. [19]Athanasiou A. Clarke A.B. Turner A.E. Kumaran N.M. Vakilpour S. Smith P.A. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death Biochemical and Biophysical Research Communications 364 2007 131 137 17931597
  16. [20]Howlett A.C. Barth F. Bonner T.I. Cabral G. Casellas P. Devane W.A. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacological Reviews 54 2002 161 202 12037135
  17. [22]Benard G. Faustin B. Passerieux E. Galinier A. Rocher C. Bellance N. Physiological diversity of mitochondrial oxidative phosphorylation American Journal of Physiology. Cell Physiology 291 2006 C1172 C1182 16807301
  18. [23]Clark J.B. Nicklas W.J. The metabolism of rat brain mitochondria. Preparation and characterization The Journal of Biological Chemistry 245 1970 4724 4731 4393961
  19. [24]Howlett A.C. Song C. Berglund B.A. Wilken G.H. Pigg J.J. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies Molecular Pharmacology 53 1998 504 510 9495818
  20. [25]McIntosh H.H. Song C. Howlett A.C. CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells Brain Research Molecular Brain Research 53 1998 163 173 9473654
  21. [26]Fukudome Y. Ohno-Shosaku T. Matsui M. Omori Y. Fukaya M. Tsubokawa H. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling The European Journal of Neuroscience 19 2004 2682 2692 15147302
  22. [27]Song C. Howlett A.C. Rat brain cannabinoid receptors are N-linked glycosylated proteins Life Sciences 56 1995 1983 1989 7776822
  23. [28]Kristian T. Isolation of mitochondria from the CNS Current Protocols in Neuroscience 2010 22 Chapter 7, Unit 7 20578034 PMC2908900
  24. [29]Horvath T.L. Diano S. Tschop M. Brain circuits regulating energy homeostasis Neuroscientist 10 2004 235 246 15155062
  25. [30]Maunsbach A.B. Afzelius B.A. Biomedical electron microscopy. Illustrated methods and interpretations 1999 Academic Press San Diego
  26. [31]Hollinshead M. Sanderson J. Vaux D.J. Anti-biotin antibodies offer superior organelle-specific labeling of mitochondria over avidin or streptavidin The Journal of Histochemistry and Cytochemistry 45 1997 1053 1057 9267466
  27. [32]Chance B. Williams G.R. A method for the localization of sites for oxidative phosphorylation Nature 176 1955 250 254 13244669

Authors
Hebert-Chatelain, E., Reguero, L., Puente, N., Lutz, B., Chaouloff, F., Rossignol, R., Piazza, P.-V., Benard, G., Grandes, P., & Marsicano, G.
Affiliations
  • University of the Basque Country (ES)
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • Université de Bordeaux (FR)
Corresponding author
Marsicano, Giovanni
Venue
Molecular Metabolism
Publisher
Elsevier BV
Published
2014-07
Volume
3
Issue
4
Pages
495-504
ISSN
2212-8778 (ISSN-L)
OpenAlex
W1994263023
Cited by
151
References
36
Citations by year
2026: 5 · 2025: 10 · 2024: 3 · 2023: 6 · 2022: 26 · 2021: 19 · 2020: 12 · 2019: 9 · 2018: 14 · 2017: 18 · 2016: 11 · 2015: 14 · 2014: 4
FWCI
11.42
Type
journal article
Language
en
Open access
Locations
  • Molecular Metabolism (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Yale University
  • European Commission (223713)
  • Agence Nationale de la Recherche (ANR-10-LABX-0043, ANR-10)
  • Institut National de la Santé et de la Recherche Médicale
  • Eusko Jaurlaritza
  • Ministerio de Economía y Competitividad
  • Euskal Herriko Unibertsitatea (RD12/0028/0004, UFI11/41)
  • Instituto de Salud Carlos III (RD12/0028/0004)
  • FP7 Ideas: European Research Council (260515)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
CB1 receptor, brain mitochondria, subcellular localization, brain bioenergetics, mitochondrial respiration, energy balance, receptor agonists, mitochondrial fractionation, experimental artifacts, immunostaining

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review